Table 1 Demographic and clinical characteristics of study patients

Age, year (mean, SD)

69.14 ± 6.13

69.20 ± 6.36

0.952

Gender, n (%)

Male

70(44)

29(48)

Female

90(56)

31(52)

0.547

BMI, kg/m² (mean, SD)

23.13 ± 1.61

23.18 ± 1.74

0.3664

Comorbidities, n (%)

Hypertension, n (%)

53(32.5)

7(11.7)

0.0015

Diabetes, n (%)

69(43.1)

5(8.3)

< 0.001

TIA/stroke, n (%)

4(2.5)

1(1.6)

0.7119

Angina, n (%)

8(5.0)

0(0)

1

Arrhythmia, n (%)

7(4.3)

2(3.3)

0.7283

Heart failure, n (%)

3(1.8)

0(0)

1

Laboratory results

Hemoglobin, g/L (mean, SD)

136.1 ± 15.48

133.6 ± 10.2

0.406

CRP, mg/L (mean, SD)

92.7 ± 65.1

4.4 ± 3.3

< 0.001

WCC, ×10⁹/L (mean, SD)

15.2 ± 8.62

8.3 ± 2.98

< 0.001

Neutrophils, ×10⁹/L (mean, SD)

6.17 ± 2.28

2.57 ± 0.81

< 0.001

Lymphocyte, ×10⁹/L (mean, SD)

1.12 ± 0.39

1.45 ± 0.15

< 0.001

NLR (mean, SD)

7.36 ± 3.73

1.78 ± 0.60

< 0.001

Total bilirubin, mmol/L (mean, SD)

17 ± 5.40

12 ± 4.39

< 0.001

GGT, U/L (mean, SD)

53 ± 12.76

61 ± 8.75

0.692

ALP, U/L (mean, SD)

92 ± 21.73

79 ± 44.93

0.274

AST, U/L (mean, SD)

28 ± 10.14

27 ± 9.08

0.619

Amylase, U/L (mean, SD)

41 ± 14.13

66 ± 37.12

< 0.001

ALT, U/L (mean, SD)

29 ± 7.29

38 ± 6.76

0.574